# | Aladdin ID | Assay Type | Description | Organism | Compounds | Reference | BAO Format | Source | |
---|---|---|---|---|---|---|---|---|---|
1. | ALA615368 | F | Compound was evaluated for the inhibition of cell replication human peripheral blood lymphocytes (PBL's). | Homo sapiens | 1 | ALA1126681 | cell-based format | Scientific Literature | |
2. | ALA699420 | F | 50% inhibition of T-cell proliferation induced by anti-CD3/anti-CD28 co-stimulation in human peripheral blood leukocytes (PBLs). | Homo sapiens | 37 | ALA1136039 | cell-based format | Scientific Literature | |
3. | ALA764459 | F | Anti -HIV activity was measured against PBLs/HIV-1 (WEJO) | Homo sapiens | 1 | ALA1127538 | cell-based format | Scientific Literature | |
4. | ALA762934 | F | Concentration that provides 50% protection in the PBL cells infected with HIV-1 BAKI strain | Homo sapiens | 1 | ALA1149920 | cell-based format | Scientific Literature | |
5. | ALA762935 | F | Concentration that provides 50% protection in the PBL cells infected with HIV-1 VIHU strain | Homo sapiens | 1 | ALA1149920 | cell-based format | Scientific Literature | |
6. | ALA762936 | F | Concentration that provides 50% protection in the PBL cells infected with HIV-1 WEJO strain | Homo sapiens | 1 | ALA1149920 | cell-based format | Scientific Literature | |
7. | ALA762937 | F | Effective concentration required for antiviral activity against lymphocyte cell line of PBL cells of Human by XTT assay | Homo sapiens | 2 | ALA1127791 | cell-based format | Scientific Literature | |
8. | ALA762938 | F | Antiviral activity against ROJO virus strain in PBLs (peripheral blood lymphocytes) | Homo sapiens | 1 | ALA1134284 | cell-based format | Scientific Literature | |
9. | ALA762939 | F | Concentration that results in 50% death of PBL cells infected with HIV-1 BAKI strain; no toxicity was observed | Homo sapiens | 1 | ALA1149920 | cell-based format | Scientific Literature | |
10. | ALA762940 | F | Concentration that results in 50% death of PBL cells infected with HIV-1 VIHU strain; no toxicity was observed | Homo sapiens | 1 | ALA1149920 | cell-based format | Scientific Literature | |
11. | ALA764484 | F | Concentration that results in 50% death of PBL cells infected with HIV-1 WEJO strain; no toxicity was observed | Homo sapiens | 1 | ALA1149920 | cell-based format | Scientific Literature | |
12. | ALA764485 | F | Cytotoxicity was measured against PBLs/HIV-1 (WEJO) | Homo sapiens | 1 | ALA1127538 | cell-based format | Scientific Literature | |
13. | ALA764486 | F | In vitro Antiviral activity against PBL cell lines | Homo sapiens | 1 | ALA1124869 | cell-based format | Scientific Literature | |
14. | ALA764487 | F | In vitro antiviral activity against PBL cell lines | Homo sapiens | 1 | ALA1124869 | cell-based format | Scientific Literature | |
15. | ALA764488 | F | In vitro Antiviral activity against PBL cell lines | Homo sapiens | 1 | ALA1124869 | cell-based format | Scientific Literature | |
16. | ALA764489 | F | In vitro antiviral activity against PBL cell lines | Homo sapiens | 1 | ALA1124869 | cell-based format | Scientific Literature | |
17. | ALA830530 | F | Percent inhibition of interleukin-5 production in human whole blood assay after 10e-6 M treatment | Homo sapiens | 21 | ALA1145205 | cell-based format | Scientific Literature | |
18. | ALA830531 | F | Percent inhibition of interleukin-5 production in human whole blood assay after 10e-7 M treatment | Homo sapiens | 21 | ALA1145205 | cell-based format | Scientific Literature | |
19. | ALA864693 | F | Reduction in peripheral blood lymphocyte count in mouse at 10 mg/kg, po relative to control | Mus musculus | 1 | ALA1138904 | organism-based format | Scientific Literature | |
20. | ALA864694 | F | Induction of peripheral blood lymphocyte in orally dosed mouse | Mus musculus | 4 | ALA1138904 | organism-based format | Scientific Literature |